Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial and fungal cytoplasmic membrane lipid bilayer is a vital structural and functional barrier that separates the internal cellular environment from the external milieu. In bacteria, this membrane is characterized by a high proportion of anionic phospholipids, such as phosphatidylglycerol, which facilitates the binding of cationic antimicrobial agents [PMID: 23412472]. Fungal membranes are distinguished by the presence of ergosterol, a sterol essential for membrane fluidity and integrity that is absent in mammalian cells [PMID: 12660211]. This target is central to numerous biological processes, including the maintenance of the electrochemical gradient (proton motive force), nutrient transport, and the coordination of cell wall synthesis. Therapeutic agents targeting the lipid bilayer, such as polymyxins, daptomycin, and amphotericin B, are typically rapidly bactericidal or fungicidal by inducing membrane depolarization or physical pore formation. Despite their high efficacy against multi-drug resistant pathogens, these agents often carry significant safety concerns, particularly nephrotoxicity, due to the potential for off-target effects on host cell membranes [PMID: 21346491]. Consequently, the microbial lipid bilayer remains a critical yet challenging target in the development of anti-infective therapies.
Drugs targeting the microbial cytoplasmic membrane lipid bilayer primarily act through physical disruption of the membrane structure. For bacteria, lipopeptides like daptomycin insert into the membrane in a calcium-dependent manner, causing rapid depolarization and ion leakage [PMID: 15105114]. Polymyxins interact with the lipid A component of lipopolysaccharides and phospholipids, leading to increased membrane permeability [PMID: 25130034]. In fungi, polyene antibiotics bind to ergosterol within the lipid bilayer, forming transmembrane pores that allow the leakage of essential intracellular components like potassium ions, leading to cell death [PMID: 12660211].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and fungal cytoplasmic membrane lipid bilayer.